Here’s the latest instalment in our news updates from Blackford Platform Partners.
Susan Wood, CEO of lung analysis firm VIDA was named as one of the top 50 healthcare technology CEOs of 2020 by The Healthcare Technology Report. The company was also featured in this article in the LA Times, which focuses on AI technologies helping to combat COVID-19, and shared an interesting case study featuring a patient with COPD who also contracted the virus.
Medical diagnostic provider MaxQ AI shared the highlights of an interview with Dr Navdeep Sangha, a neurologist at Kaiser Permanente Los Angeles Medical Center. Dr. Sangha shares his insight into how AI-powered diagnostic solutions are poised to augment acute care providers in the detection of intracranial hemorrhage (ICH). MaxQ AI also revealed a case study with Capital Health that showed how the company’s ACCIPIO product retrospectively flagged a CT case where ICH had not been detected as being suspected of ICH.
After announcing CE clearance in our previous newsletter, imaging AI specialist icometrix has secured FDA permission for its icolung solution, which quantifies the lung involvement on chest CT in patients admitted with COVID-19.The company’s icompanion web app for remote monitoring of people with neurological conditions was officially launched on World MS Day. icometrix also made new webinar recordings available, including this one on atrophy in MS.
Medical 3D printing specialist axial3D continues to pivot its business to support the fight against COVID-19 by producing 3D printed nasopharyngeal swabs and face shields for healthcare workers. The company was also featured alongside NASA, BMW and others in NVIDIA’s powerful ‘I am AI’ video, and presented a webinar with Formlabs and 3DNatives on the benefits of 3D printing for surgeons and patients.
And finally, musculoskeletal AI solutions developer Image Biopsy Lab was pleased to announce that its IB Lab KOALA product for knee osteoarthritis supported the development of a new research paper by Danube University Krems. The paper makes the case for a new quantitative measure of joint space width (JSW) called “standardized JSW”. The paper finds that standardized JSW sets a new benchmark for assessment of loss of cartilage in knee osteoarthritis.
Stay tuned for more partner news next month!